138 related articles for article (PubMed ID: 12190952)
1. Variability of Nt-proANP and C-ANP.
McDowell G; Patterson C; Maguire S; Shaw C; Nicholls DP; Hall C
Eur J Clin Invest; 2002 Aug; 32(8):545-8. PubMed ID: 12190952
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
[TBL] [Abstract][Full Text] [Related]
3. Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.
McKie PM; Cataliotti A; Sangaralingham SJ; Ichiki T; Cannone V; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
Mayo Clin Proc; 2011 Dec; 86(12):1154-60. PubMed ID: 22134933
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
Franz M; Woloszczuk W; Hörl WH
Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
[TBL] [Abstract][Full Text] [Related]
7. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
[TBL] [Abstract][Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
13. Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease.
Macaulay Hunter EF; Kelly PA; Prowse C; Woods RJ; Lowry PJ
Scand J Clin Lab Invest; 1998 May; 58(3):205-16. PubMed ID: 9670344
[TBL] [Abstract][Full Text] [Related]
14. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Dong H; Chen DQ; Wang Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
[TBL] [Abstract][Full Text] [Related]
15. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
[TBL] [Abstract][Full Text] [Related]
17. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure.
Azizi C; Maistre G; Kalotka H; Isnard R; Barthélemy C; Masson F; Pham P; Pousset F; Eurin J; Lechat P; Komajda M; Carayon A
J Endocrinol; 1996 Jan; 148(1):51-7. PubMed ID: 8568471
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
